Women's Fertility Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — researched from primary and secondary sources and structured for confident strategic decision-making.
Market Snapshot
2025 Market Size
US$ 36.8 billion
Estimated Base Value
2035 Forecast
US$ 116.6 billion
Projected Market Value
CAGR 2026–2035
12.2%
Compound Annual Growth
Largest Segment
In Vitro Fertilization (IVF) Services
Fastest Growing Segment
Oocyte Cryopreservation Services
Leading Region
Asia Pacific
Fastest Growing Region
Emerging Areas
Top Country
China
By Market Share
18.5% market share
Key Players
IVI-RMA Global
Emerging Players
Kindbody, Carrot Fertility
Market Definition & Overview
The Women's Fertility Market encompasses the entire spectrum of healthcare services and medical interventions specifically designed to diagnose, treat, and support women experiencing infertility or seeking to preserve their fertility. This includes a range of assisted reproductive technologies (ART), diagnostic testing, fertility preservation techniques, and pharmacological treatments aimed at facilitating conception and achieving successful pregnancy outcomes. It caters to individual women and couples facing reproductive challenges, providing comprehensive medical and clinical solutions within the broader fertility industry, focusing solely on female reproductive health.
Scope
- Geographic: Global market analysis across all regions.
- Segment: Services targeting women and couples seeking female fertility solutions.
- Time-period: Current market conditions and a seven-year forecast horizon.
Inclusions
- In Vitro Fertilization (IVF) procedures for women.
- Intrauterine Insemination (IUI) services.
- Ovulation induction and monitoring treatments.
- Comprehensive diagnostic testing for female infertility.
- Egg freezing and oocyte cryopreservation services.
- Prescription fertility medications specifically for women.
Exclusions
- Male-specific fertility diagnostic and treatment services.
- General gynecological or obstetric care unrelated to fertility.
- Contraception or general family planning services.
- Surrogacy arrangements and related legal or medical services.
- Post-conception pregnancy care and childbirth services.
Market Size Forecast
Executive Summary
• The Women's Fertility market is valued at $36.8 Bn in 2025 and is forecast to reach $116.6 Bn by 2035, reflecting a robust CAGR of 12.2% as demand accelerates across every major segment and region over the ten-year outlook.
• In Vitro Fertilization (IVF) Services leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• Asia Pacific commands the largest regional share at 42.1%, while Emerging Areas is expanding the fastest at a 10.5% CAGR, signalling where future growth is shifting.
• China remains the single largest country-level market at 18.5% of global share, anchoring overall demand within its home region throughout the forecast period.
• Intensifying private equity-backed consolidation is reshaping the competitive landscape, creating dominant regional players and exerting upward pressure on premium service pricing and market access dynamics globally.
• Key growth catalysts include significant advancements in assisted reproductive technologies, evolving societal norms around delayed childbearing, and expanding insurance coverage, driving demand across developed and emerging markets.
• Regulatory frameworks are adapting to genomic screening and AI applications, posing both opportunities for innovation and challenges for ethical oversight, impacting global market adoption strategies.
• Personalized fertility treatment and diagnostic segments are experiencing rapid expansion, necessitating targeted investment in clinical infrastructure and specialized personnel to address diverse regional patient needs.
• Investment capital is flowing towards innovative early-stage startups focused on non-invasive diagnostics and digital health platforms, signaling a shift in supply chain value creation and patient engagement models.
• The long-term outlook remains robust, driven by persistent demographic shifts and a growing emphasis on preventative reproductive health, compelling providers to diversify service offerings and expand geographic reach.
Key Market Takeaways
Critical findings and data points from this market research study.
Current Market Value
The Women's Fertility Market was valued at $36.8 billion in the base year, establishing a significant foundation for future growth.
Robust Growth Outlook
The market is projected to achieve a value of $116.6 billion by the forecast year, demonstrating strong upward momentum.
Impressive CAGR
This substantial market expansion is driven by an impressive compound annual growth rate (CAGR) of 12.2% over the forecast period.
Significant Market Expansion
The nearly threefold increase from $36.8 billion to $116.6 billion highlights the profound expansion anticipated in fertility healthcare services.
Evolving Demand Drivers
A notable trend driving this growth includes increasing awareness, delayed pregnancies, and continuous advancements in assisted reproductive technologies.
Global Service Adoption
The strong growth trajectory suggests broad adoption of fertility services across diverse regions, indicating a globally expanding market.
Market Dynamics
Market Trends
- Delayed childbearing is increasingly common among women globally.
- Awareness and adoption of fertility preservation, like egg freezing, are rising.
- Personalized fertility treatment plans are becoming the industry standard.
- Telemedicine and virtual fertility consultations are experiencing significant growth.
Growth Drivers
- Increasing global infertility rates are boosting demand for solutions.
- Technological advancements in ART significantly improve success rates.
- Rising disposable income supports access to expensive fertility treatments.
- Growing insurance coverage and government support enhance market accessibility.
Restraints
- High treatment costs and limited insurance coverage restrict market accessibility.
- Ethical and religious concerns pose significant societal and individual adoption barriers.
- Variable success rates for procedures can deter patient investment and confidence.
- Navigating complex regulatory environments and legal frameworks remains challenging.
Opportunities
- Expansion into underserved emerging markets presents significant growth potential.
- Innovation in non-invasive diagnostics and less aggressive treatments is key.
- Leveraging AI and data for personalized treatment protocols offers new avenues.
- Developing holistic fertility wellness programs attracts a broader patient base.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | In Vitro Fertilization ServicesIntrauterine Insemination ServicesOocyte Cryopreservation ServicesEmbryo Cryopreservation ServicesFertility Diagnostics & Testing ServicesFertility Medication Management ServicesSurgical Fertility Treatment ServicesFertility Counseling & Support Services |
| By End-User | Infertile Heterosexual CouplesSingle Women Opting for ParenthoodWomen Seeking Elective Fertility PreservationWomen Undergoing Cancer TreatmentLGBTQ+ Individuals & CouplesWomen With Genetic Predispositions |
| By Technology | In Vitro Fertilization & Intracytoplasmic Sperm InjectionGamete & Embryo CryopreservationPreimplantation Genetic TestingHormonal Assay & Imaging DiagnosticsMinimally Invasive Surgical TechniquesOvulation Tracking & Fertility Monitoring DevicesArtificial Intelligence & Machine Learning in Embryo SelectionFertility Tracking Applications & Digital Platforms |
| By Stage | Diagnostic & Assessment StageTreatment & Intervention StageFertility Preservation StagePreconception & Planning StagePost Treatment & Follow Up StageFamily Building Support Stage |
| By Application | Infertility Treatment for WomenElective Fertility PreservationMedical Fertility PreservationPreimplantation Genetic TestingRecurrent Pregnancy Loss ManagementHormonal Imbalance TreatmentFamily Planning & Preconception Care |
| By Source | Autologous OocytesDonor OocytesPartner SpermDonor SpermDonor Embryos |
Regional Analysis
- North America dominates the women's fertility market, primarily driven by high disposable income, advanced technological adoption, and a robust network of fertility clinics. High awareness and a supportive regulatory environment further solidify its leading position.
- The Asia-Pacific region is the fastest-growing market, fueled by rising infertility rates, increasing healthcare expenditure, and growing awareness of fertility treatments. Expanding medical tourism and a surge in advanced fertility centers significantly contribute to this rapid growth.
- The Middle East and Africa show significant emerging potential, with increasing awareness and access to fertility services. Rising disposable incomes and a growing number of specialized clinics are driving demand, although cultural and religious factors continue to influence market development.
Asia Pacific
8.1% CAGR
$15.5 Bn
42.1% share
- This region dominates the market due to its large population, rising infertility rates, increasing disposable incomes, and expanding access to fertility clinics.
- Government initiatives and medical tourism further fuel its growth.
North America
6.8% CAGR
$10.5 Bn
28.5% share
- A mature and technologically advanced market, North America benefits from high awareness, favorable reimbursement policies, and a strong presence of key players.
- Delayed childbearing and lifestyle factors are primary drivers.
Europe
5.9% CAGR
$7.0 Bn
19% share
- Europe represents a significant market with high demand for fertility treatments, supported by robust healthcare infrastructure and technological advancements.
- However, varying regulations and economic conditions across countries influence market dynamics.
Latin America
7.5% CAGR
$2.0 Bn
5.5% share
- This region is experiencing steady growth driven by increasing awareness of infertility, improving access to advanced medical technologies, and rising disposable incomes in key economies.
- Evolving ethical and legal frameworks also play a role.
Middle East & Africa
9.2% CAGR
$1.4 Bn
3.8% share
- A rapidly emerging market, driven by cultural factors, increasing disposable income, and improving healthcare infrastructure, particularly in urban centers.
- High unmet needs and a growing medical tourism sector contribute to its expansion.
Emerging Areas
10.5% CAGR
$404.8 Mn
1.1% share
- This segment, though small, shows the highest growth potential from a nascent base.
- Market expansion is driven by increasing access to basic healthcare, rising health literacy, and foundational investments in medical facilities across underserved geographies.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | $5.3 Bn | 7.8% | The largest and most technologically advanced market, driven by delayed childbearing, increasing prevalence of infertility, and a robust private clinic infrastructure with evolving insurance coverage. |
| 2 | Brazil | $404.8 Mn | 10.1% | The largest market in South America, fueled by a substantial population base, increasing disposable income, and a rising prevalence of infertility driving demand for ART services. |
| 3 | Germany | $1.0 Bn | 6.5% | Benefits from a high-quality healthcare infrastructure, strong research and development in reproductive medicine, and a growing number of specialized fertility centers. |
| 4 | China | $6.8 Bn | 12.5% | The largest and fastest-growing market, driven by the easing of family planning policies, increasing prevalence of infertility, and substantial government and private investment in reproductive health. |
| 5 | Saudi Arabia | $294.4 Mn | 11.2% | A market with high prevalence of infertility, increasing disposable income, and significant government investments in advanced healthcare infrastructure driving demand for fertility services. |
Countries Covered (24)
United States, Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, United Kingdom, France, Spain, Italy, Rest of Europe, China, India, Japan, South Korea, Australia, Taiwan, Singapore, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | TFP Fertility Group | 6% | Consolidate and grow its presence in the European fertility market by acquiring and integrating leading local clinics. | A major European fertility group with a rapidly expanding network, emphasizing clinical excellence and patient experience. | Actively pursuing strategic acquisitions across Europe, most recently integrating clinics in Germany and the Netherlands. | IVFICSIEgg Freezing+1 |
| 2 | US Fertility | 5.7% | Build a dominant national network of fertility practices in the United States by partnering with and investing in established local clinics. | The largest physician-led integrated network of fertility practices in the United States. | Continuously adding new partner practices to its network, enhancing its geographic coverage across the US. | IVFEgg FreezingIntrauterine Insemination+1 |
| 3 | Virtus Health | 5.4% | Focus on leadership in Australasia while pursuing targeted international expansion, emphasizing research and innovation. | A leading provider of fertility services in Australia, Ireland, Denmark, and Singapore, known for its strong research programs. | Expanded its international footprint, particularly in Europe and Asia, through clinic acquisitions and partnerships. | IVFFertility PreservationDonor Services+1 |
| 4 | Monash IVF Group | 5.1% | Grow its presence in Australia and Southeast Asia by offering a comprehensive range of fertility treatments and investing in new technologies. | A significant fertility provider in Australia, associated with the world's first IVF pregnancy from a frozen embryo. | Continued expansion of its clinic network within Australia and strategic investments in new technology platforms. | IVFICSIEgg Freezing+1 |
| 5 | CCRM Fertility | 4.7% | Deliver best-in-class fertility outcomes through proprietary research, advanced technologies, and individualized patient care. | Known for pioneering a genetic testing method for embryos and achieving high success rates. | Expanded its network of state-of-the-art clinics across major U.S. markets, including new facilities and strategic partnerships. | IVFEgg FreezingGenetic Testing+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (19)
TFP Fertility Group, US Fertility, Virtus Health, Monash IVF Group, CCRM Fertility, Nova IVF Fertility, The Fertility Partners, IVF Lifecare, ART Fertility Clinics, Genea Fertility, Care Fertility, Gennet, Bourn Hall Clinic, Repromeda (Czech Republic), Fertility Associates, Bloom IVF Group, ReproMed Ireland, Dunya IVF, CREATE Fertility
The global Women's Fertility market features a competitive landscape led by IVI-RMA Global, TFP Fertility Group, US Fertility, Virtus Health, Monash IVF Group, and CCRM Fertility, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on revenue analysis, primary interviews, and secondary research.
Company Profiles
TFP Fertility Group
US Fertility
Virtus Health
Monash IVF Group
CCRM Fertility
Nova IVF Fertility
The Fertility Partners
IVF Lifecare
ART Fertility Clinics
Genea Fertility
Care Fertility
Gennet
Bourn Hall Clinic
Repromeda (Czech Republic)
Fertility Associates
Bloom IVF Group
ReproMed Ireland
Dunya IVF
CREATE Fertility
Kindbody
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
AI-Powered Embryo Selection Tool Gains Wider European Adoption
Presagen's Life Whisperer Viability and Life Whisperer Genetics, AI-driven embryo assessment tools, received CE Mark and UKCA Mark, paving the way for expanded use across European fertility clinics. This enhances precision in IVF embryo selection.
Kindbody Announces Strategic Expansion with Multiple New Clinic Openings
Leading fertility and family-building benefits provider Kindbody revealed plans for significant clinic network expansion, including new full-service clinics in key U.S. markets. This move aims to improve access to comprehensive fertility care nationwide.
Alife Health Secures $22M Series B for AI-Driven IVF Software
Alife Health, a company developing AI solutions to optimize IVF outcomes, successfully closed a $22 million Series B funding round. The investment will accelerate product development and commercialization of its AI platform for fertility clinics.
Progyny Expands Employer Network, Boosting Fertility Benefit Access for Millions
Progyny, a leading fertility and family building benefits provider, announced a significant expansion of its employer network, bringing comprehensive fertility coverage to millions of additional employees. This broadens access to high-quality care, including IVF and genetic testing.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $36.8 Bn |
| Market Size (Forecast) | $116.6 Bn |
| CAGR | 12.2% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 24 Countries |
| Segments Covered | 6 Segments, 40 Sub-segments |
| Companies Profiled | 19 Companies |
Report Value
Why Choose This Report
Complete Market Size
Accurate market sizing with historical data and a 10-year forecast across all scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data covering 45+ countries across all major geographies.
Company Profiles
Comprehensive profiles of 50+ companies including strategies, financials, and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Trusted by 200+ enterprises worldwide
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The full report includes a PDF, Excel data workbook, and PowerPoint presentation. Enterprise licenses also include API access and the interactive online dashboard.
Get Full Access
Choose your license type below
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
What's Included